Insider Trading & Ownership of Third Rock Ventures II, L.P.

Location: Boston, MA
Summary: The estimated value of insider holdings of Third Rock Ventures II, L.P. is at least $10,980,202 dollars as of 17 Sep 2021. Third Rock Ventures II, L.P. is the 10%+ Owner of Jounce Therapeutics, Inc. and owns shares of Jounce Therapeutics, Inc. stock worth about $10.63M. Third Rock Ventures II, L.P. is the 10%+ Owner of Revolution Medicines, Inc. and owns shares of Revolution Medicines, Inc. (RVMD) stock worth about $349K.
Signature: /s/ Kevin Gillis, Chief Operating Officer of TRV GP II, LLC, general partner of Third Rock Ventures GP II, L.P., general partner of Third Rock Ventures II, L.P.
All Insider Reports: All Insider Reports

Notify me when Third Rock Ventures II, L.P. files a new Insider Trading report.

Ownership of Third Rock Ventures II, L.P.

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
JNCE	Jounce Therapeutics, Inc.	10%+ Owner	$10,631,227			15 Sep 2021
RVMD, RVMDW	Revolution Medicines, Inc.	10%+ Owner	$348,975			03 Jun 2021

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.